Publications by authors named "M Ambrosini"

Claim this Profile
P
Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial.
Eleonora Cristarella, Margherita Ambrosini, Massimo Di Maio, Sara Lonardi, Ferdinando De Vita

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CtDNA detection with low-pass whole genome bisulfite sequencing in RAS wild-type metastatic colorectal cancer: an exploratory objective of the VALENTINO trial.
Paolo Manca, Marta Paoli, Francesca Galardi, Federica Morano, Samantha Di Donato, Margherita Ambrosini

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter study.
Aziz Zaanan, Elisabeth Sophie Bergen, Ludovic Evesque, Aurelia Meurisse, Pascal Artru, Margherita Ambrosini

J Natl Cancer Inst· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.
Alessandra Raimondi, Gabriele Tinè, Alexej Ballhausen, Sara Lonardi, David Tougeron, Margherita Ambrosini

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment.
M Ambrosini, H Blons, S Garinet, C Mulot, D Le Corre

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis